C8772
Cholera filtrate
lyophilized powder, bacterial sialidase receptor-destroying enzyme (RDE)
Sinónimos:
Cholera Filter
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Acerca de este artículo
UNSPSC Code:
12352200
NACRES:
NA.77
Form:
lyophilized powder
Quality level:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleServicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Cholera filtrate, lyophilized powder
form
lyophilized powder
Quality Level
storage temp.
2-8°C
Categorías relacionadas
General description
Cholera filtrate promotes the activation of adenylate cyclase. It does not affect the activity of cyclic adenosine monophosphate (cAMP) phosphodiesterase.
Application
Cholerafiltrate has been used as a receptor destroying enzyme (RDE): inhemagglutination inhibition assay of serum samples, in microneutralizationassay of mice serum samples, in hemagglutination inhibition assay to removenon-specific inhibitors from the cell culture supernatant samples
Biochem/physiol Actions
Cholera filtrate is a bacterial sialidase receptor-destroying enzyme (RDE) and may be used as crude neuraminidase. It may also be used in serological testing for influenza.
Preparation Note
After reconstituting with 5ml sterile water, it will contain 0.01% MIT as preservative.
Other Notes
See a separate listing of neuraminidase for preparations showing higher activity.
Disclaimer
For research use only. Not for use in diagnostic procedures.
signalword
Danger
flash_point_f
Not applicable
flash_point_c
Not applicable
supp_hazards
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1A - Skin Sens. 1
Clase de almacenamiento
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins
Daniela M, et al.
Nature Communications (2024)
Ilana Fox-Fisher et al.
eLife, 10 (2021-11-30)
Blood cell counts often fail to report on immune processes occurring in remote tissues. Here, we use immune cell type-specific methylation patterns in circulating cell-free DNA (cfDNA) for studying human immune cell dynamics. We characterized cfDNA released from specific immune
A Riccomi et al.
Vaccines, 12(4) (2024-04-27)
A number of studies have suggested that influenza vaccination can provide protection against COVID-19, but the underlying mechanisms that could explain this association are still unclear. In this study, the effect of the 2021/2022 seasonal influenza vaccination on the immune
WHO Tech Rep. Serv.
WHO Expert Committee on Influenza, 64 (1953)
Yao Lu et al.
Vaccine, 38(10), 2387-2395 (2020-02-06)
The highly pathogenic avian influenza (HPAI) H5N1 viruses and their spillover into the human population pose substantial economic and public health threats. Although antiviral drugs have some effect in treating influenza infection, vaccination is still the most effective intervention to
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico